{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:20:31Z","timestamp":1759882831501,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Journal Armed Forces India"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.mjafi.2022.06.011","type":"journal-article","created":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T06:59:33Z","timestamp":1661065173000},"page":"S209-S216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S1","title":["An observational study of severe cutaneous adverse reactions at a tertiary care teaching hospital"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0297-5760","authenticated-orcid":false,"given":"K.","family":"Lekshmipriya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pradeesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biju","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahashweta","family":"Dash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aradhana","family":"Sood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3060-8722","authenticated-orcid":false,"given":"Vinay","family":"Gera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mjafi.2022.06.011_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/ijd.IJD_591_17","article-title":"Recent advances in severe cutaneous adverse drug reaction","volume":"63","author":"Das","year":"2018","journal-title":"Indian J Dermatol"},{"issue":"6","key":"10.1016\/j.mjafi.2022.06.011_bib2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1046\/j.1365-2125.1999.00096.x","article-title":"Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions","volume":"48","author":"Naldi","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.mjafi.2022.06.011_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0378-6323.74963","article-title":"Severe cutaneous adverse reactions","volume":"77","author":"Grover","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.mjafi.2022.06.011_bib4","first-page":"20","article-title":"Adverse cutaneous drug reactions: clinical pattern and causative agents in a tertiary care center in South India","volume":"70","author":"Pudukadan","year":"2004","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2","key":"10.1016\/j.mjafi.2022.06.011_bib5","first-page":"395","article-title":"Adverse cutaneous drug reactions with special reference to non-steroidal anti inflammatory drugs in a tertiary care hospital in Tamil N\u0101du-South India","volume":"3","author":"Manivannan","year":"2012","journal-title":"Int J Pharma Bio Sci"},{"key":"10.1016\/j.mjafi.2022.06.011_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/2229-516X.81982","article-title":"Cutaneous adverse drug reactions in a tertiary care teaching hospital: a North Indian perspective","volume":"1","author":"Nandha","year":"2011","journal-title":"Int J App Basic Med Res"},{"key":"10.1016\/j.mjafi.2022.06.011_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4103\/0019-5154.147834","article-title":"Severe cutaneous adverse drug reactions: a clinic-epidemiological study","volume":"60","author":"Sasidharanpillai","year":"2015","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.mjafi.2022.06.011_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4103\/0378-6323.174416","article-title":"A study of severe cutaneous adverse reactions to drugs with special reference to treatment outcome","volume":"82","author":"Devi","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.mjafi.2022.06.011_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/0378-6323.38431","article-title":"Clinical study of cutaneous drug eruption in 200 patients","volume":"74","author":"Patel Raksha","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.mjafi.2022.06.011_bib10","doi-asserted-by":"crossref","first-page":"618","DOI":"10.4103\/ijd.IJD_703_16","article-title":"Cutaneous adverse drug reactions in a tertiary care teaching hospital in India: an intensive monitoring study","volume":"62","author":"Thakkar","year":"2017","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.mjafi.2022.06.011_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2334-10-49","article-title":"Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus\u00a06 infection or to allergy-mediated viral reactivation? Report of a case and literature review","volume":"10","author":"Gentile","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.mjafi.2022.06.011_bib12","first-page":"577","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a complex interaction of drugs, viruses and the immune system","volume":"14","author":"Criado","year":"2012","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.mjafi.2022.06.011_bib13","first-page":"347","article-title":"Current concepts on the diagnosis and pathogenesis of drug-induced hypersensitivity syndrome","volume":"52","author":"Shiohara","year":"2009","journal-title":"Japan Med Assoc J"},{"key":"10.1016\/j.mjafi.2022.06.011_bib14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2332\/allergolint.11-OA-0309","article-title":"Statistical analysis of Stevens-Johnson syndrome caused by Mycoplasma pneumonia infection in Japan","volume":"60","author":"Kunimi","year":"2011","journal-title":"Allergol Int"},{"issue":"2","key":"10.1016\/j.mjafi.2022.06.011_bib15","first-page":"195","article-title":"Reactivation of cytomegalovirus in a patient with stevens-Johnson syndrome-toxic epidermal necrolysis","volume":"38","author":"Tagajdid","year":"2013","journal-title":"Iran J Med Sci"},{"key":"10.1016\/j.mjafi.2022.06.011_bib16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1503\/cmaj.090401","article-title":"Prevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screening","volume":"182","author":"Fernando","year":"2010","journal-title":"CMAJ (Can Med Assoc J)"},{"key":"10.1016\/j.mjafi.2022.06.011_bib17","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2011.004","article-title":"Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis","volume":"3","author":"Khalaf","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.mjafi.2022.06.011_bib18","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","article-title":"Defective regulatory T cells\u00a0in\u00a0patients with severe drug eruptions: timing of\u00a0the\u00a0dysfunction is associated with the pathological\u00a0phenotype and outcome","volume":"182","author":"Takahashi","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.mjafi.2022.06.011_bib19","doi-asserted-by":"crossref","first-page":"586407","DOI":"10.3389\/fphar.2020.586407","article-title":"Viral infections and cutaneous drug-related eruptions","volume":"11","author":"Anci","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.mjafi.2022.06.011_bib20","doi-asserted-by":"crossref","first-page":"e1048","DOI":"10.7205\/MILMED-D-13-00139","article-title":"Toxic epidermal necrolysis from suspected Mycoplasma pneumoniae infection","volume":"178","author":"McDermott","year":"2013","journal-title":"Mil Med"},{"key":"10.1016\/j.mjafi.2022.06.011_bib21","doi-asserted-by":"crossref","first-page":"740","DOI":"10.4103\/ijccm.IJCCM_212_18","article-title":"Methotrexate-induced toxic epidermal necrolysis: a rare case report and review of literature","volume":"22","author":"Kataria","year":"2018","journal-title":"Indian J Crit Care Med"},{"key":"10.1016\/j.mjafi.2022.06.011_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/0019-5154.108094","article-title":"Methotrexate-induced toxic epidermal necrolysis in a child","volume":"58","author":"Gogia","year":"2013","journal-title":"Indian J Dermatol"}],"container-title":["Medical Journal Armed Forces India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123722000946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123722000946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T11:53:23Z","timestamp":1759838003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0377123722000946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":22,"alternative-id":["S0377123722000946"],"URL":"https:\/\/doi.org\/10.1016\/j.mjafi.2022.06.011","relation":{},"ISSN":["0377-1237"],"issn-type":[{"type":"print","value":"0377-1237"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An observational study of severe cutaneous adverse reactions at a tertiary care teaching hospital","name":"articletitle","label":"Article Title"},{"value":"Medical Journal Armed Forces India","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mjafi.2022.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}